Comparison of Clinical Trial Outcome Patterns in Patients Following Acute Coronary Syndromes and in Patients With Chronic Stable Atherosclerosis-Reference-Cited by-同舟云学术

Comparison of Clinical Trial Outcome Patterns in Patients Following Acute Coronary Syndromes and in Patients With Chronic Stable Atherosclerosis

Published:2014-02-25 Issue:6 Volume:37 Page:337-342
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clin Cardiol

Author:

Mahaffey Kenneth W.¹²,Wojdyla Daniel M.¹,Pieper Karen S.¹,Tricoci Pierluigi¹,Alexander John H.¹,Lincoff A. Michael³,Brennan Danielle M.³,Bhatt Deepak L.⁴,Wallentin Lars⁵,Harrington Robert A.²

Affiliation:

1. Duke Clinical Research Institute; Durham North Carolina

2. Department of Medicine; Stanford University; Stanford California

3. C5 Research; Cleveland Clinic; Cleveland Ohio

4. Brigham and Women's Hospital and Harvard Medical School; Boston Massachusetts

5. Department of Medical Sciences; Cardiology and Uppsala Clinical Research Center; Uppsala University; Uppsala Sweden

Funder

Merck & Co., Inc.

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference11 articles.

1. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons;Fihn;J Am Coll Cardiol.,2012

2. Ticagrelor versus clopidogrel in patients with acute coronary syndromes;Wallentin;N Engl J Med.,2009

3. Thrombin-receptor antagonist vorapaxar in acute coronary syndromes;Tricoci;N Engl J Med.,2012

4. Apixaban with antiplatelet therapy after acute coronary syndrome;Alexander;N Engl J Med.,2011

5. Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease;Topol;Circulation.,2003

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of acute coronary syndrome on clinical outcomes after revascularization with the dual‐therapy CD34 antibody‐covered sirolimus‐eluting Combo stent and the sirolimus‐eluting Orsiro stent;Catheterization and Cardiovascular Interventions;2022-11-15

2. Cardiovascular Risk Factors and Secondary Events Among Acute and Chronic Stable Myocardial Infarction Patients: Findings from a Managed Care Database;Cardiology and Therapy;2019-08-20

3. Personalized benefit‐risk assessments combining clinical trial and real‐world data provide further insights into which patients may benefit most from therapy: Demonstration for a new oral antiplatelet therapy;Pharmacoepidemiology and Drug Safety;2019-03-07

4. The chronic ischaemic cardiovascular disease ESC Pilot Registry: Results of the six-month follow-up;European Journal of Preventive Cardiology;2018-01-16

5. Fractional Flow Reserve-Guided Strategy in Acute Coronary Syndrome. A Systematic Review and Meta-Analysis;Arquivos Brasileiros de Cardiologia;2018